Pomerantz LLP

NEW YORK, Feb. 4, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of  Proficient Auto Logistics, Inc. (“Proficient Auto Logistics” or the “Company”) (NASDAQ: PAL).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Proficient Auto Logistics and certain of its officers and/or directors … Read more

NEW YORK, Dec. 27, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Arvinas, Inc. (“Arvinas” or the “Company”) (NASDAQ: ARVN). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Arvinas and certain of its officers and/or directors have engaged in securities fraud or … Read more

NEW YORK, Nov. 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Visa Inc. (“Visa” or the “Company”) (NYSE: V).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Visa and certain of its officers and/or directors have engaged in securities fraud or other … Read more

NEW YORK, July 24, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Skye Bioscience, Inc. (“Skye” or the “Company”) (NASDAQ: SKYE). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Skye and certain of its officers and/or directors have engaged in securities fraud or other … Read more

NEW YORK, July 2, 2024 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Biomea Fusion, Inc. (“Biomea” or the “Company”) (NASDAQ: BMEA). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Biomea and certain of its officers and/or directors have engaged in securities fraud … Read more

NEW YORK, Jan. 30, 2024 /PRNewswire/ — Pomerantz LLP announces that a class action lawsuit has been filed against BioNTech SE (“BioNTech” or the “Company”) (NASDAQ: BNTX). The class action, filed in the United States District Court for the Central District of California, and docketed under 24-cv-00337, is on behalf of a class consisting of … Read more